Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: PharmaSGP achieves record revenues in 2021 and exceeds analysts' expectations
DGAP-News: PharmaSGP achieves record revenues in 2021 and exceeds analysts' expectations
DGAP-News: PharmaSGP achieves record revenues in 2021 and exceeds analysts' expectations
eqs_en 
0 17.02.22
EQS-Adhoc: Phoenix Mecano posts double-digit growth and doubles its operating result
EQS-Adhoc: Phoenix Mecano posts double-digit growth and doubles its operating result
EQS-Adhoc: Phoenix Mecano posts double-digit growth and doubles its operating result
eqs_en 
0 17.02.22
Swiss Prime Site 2021: targets clearly exceeded
Swiss Prime Site 2021: targets clearly exceeded
Swiss Prime Site 2021: targets clearly exceeded
eqs_en 
0 17.02.22
SC Freiburg implements world's largest photovoltaic system on a stadium roof with Meyer Burger solar modules
SC Freiburg implements world's largest photovoltaic system on a stadium roof with Meyer Burger solar modules
SC Freiburg implements world's largest photovoltaic system on a stadium roof with Meyer Burger solar modules
eqs_en 
0 17.02.22
Key Figures 15.02.2022
Key Figures 15.02.2022
Key Figures 15.02.2022
eqs_en 
0 16.02.22
Welcome back: free coffee for commuters at k kiosk and avec
Welcome back: free coffee for commuters at k kiosk and avec
Welcome back: free coffee for commuters at k kiosk and avec
eqs_en 
0 16.02.22
DGAP-Adhoc: DFV Deutsche Familienversicherung AG: DFV expects significantly better 2021 results
DGAP-Adhoc: DFV Deutsche Familienversicherung AG: DFV expects significantly better 2021 results
DGAP-Adhoc: DFV Deutsche Familienversicherung AG: DFV expects significantly better 2021 results
eqs_en 
0 16.02.22
DGAP-News: CLIQ Digital adds over 400 hours of award-winning series content
DGAP-News: CLIQ Digital adds over 400 hours of award-winning series content
DGAP-News: CLIQ Digital adds over 400 hours of award-winning series content
eqs_en 
0 16.02.22
NCSP Group's consolidated cargo turnover for 12M 2021 grows 4.5% YoY
NCSP Group's consolidated cargo turnover for 12M 2021 grows 4.5% YoY
NCSP Group's consolidated cargo turnover for 12M 2021 grows 4.5% YoY
eqs_en 
0 16.02.22
Notification of managers' transactions
Notification of managers' transactions
Notification of managers' transactions
eqs_en 
0 16.02.22
Rights and Issues Investment Trust PLC:
Rights and Issues Investment Trust PLC:
Rights and Issues Investment Trust PLC:
eqs_en 
0 16.02.22
DGAP-News: IKB Deutsche Industriebank AG: Dr. Ralph Müller to leave the IKB Board of Managing Directors
DGAP-News: IKB Deutsche Industriebank AG: Dr. Ralph Müller to leave the IKB Board of Managing Directors
DGAP-News: IKB Deutsche Industriebank AG: Dr. Ralph Müller to leave the IKB Board of Managing Directors
eqs_en 
0 16.02.22
Chelverton UK Dividend Trust plc:
Chelverton UK Dividend Trust plc:
Chelverton UK Dividend Trust plc:
eqs_en 
0 16.02.22
Fuller, Smith & Turner PLC: Holding(s) in Company
Fuller, Smith & Turner PLC: Holding(s) in Company
Fuller, Smith & Turner PLC: Holding(s) in Company
eqs_en 
0 16.02.22
Turkiye Garanti Bankasi A.S.: Principal and Coupon payments of Bank Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Principal and Coupon payments of Bank Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Principal and Coupon payments of Bank Bonds to Qualified Investors
eqs_en 
0 16.02.22
DGAP-News: Exasol AG provides overview of fiscal year 2021 and outlook for 2022
DGAP-News: Exasol AG provides overview of fiscal year 2021 and outlook for 2022
DGAP-News: Exasol AG provides overview of fiscal year 2021 and outlook for 2022
eqs_en 
0 16.02.22
Magnit opens hybrid dark store
Magnit opens hybrid dark store
Magnit opens hybrid dark store
eqs_en 
0 16.02.22
DGAP-News: Defence Therapeutics Inc.: DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER
DGAP-News: Defence Therapeutics Inc.: DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER
DGAP-News: Defence Therapeutics Inc.: DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER
eqs_en 
0 16.02.22
AEW UK REIT plc: Acquisition of PRYZM Nightclub, Cardiff
AEW UK REIT plc: Acquisition of PRYZM Nightclub, Cardiff
AEW UK REIT plc: Acquisition of PRYZM Nightclub, Cardiff
eqs_en 
0 16.02.22
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
eqs_en 
0 16.02.22
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
eqs_en 
0 16.02.22
DGAP-News: Intershop looks back on successful financial year 2021 and remains on profitable growth track thanks to strengthened cloud business
DGAP-News: Intershop looks back on successful financial year 2021 and remains on profitable growth track thanks to strengthened cloud business
DGAP-News: Intershop looks back on successful financial year 2021 and remains on profitable growth track thanks to strengthened cloud business
eqs_en 
0 16.02.22
Cembra reports resilient results with record net income
Cembra reports resilient results with record net income
Cembra reports resilient results with record net income
eqs_en 
0 16.02.22
Dufry extends its duty-free and duty-paid concession at Helsinki Airport for a further five years
Dufry extends its duty-free and duty-paid concession at Helsinki Airport for a further five years
Dufry extends its duty-free and duty-paid concession at Helsinki Airport for a further five years
eqs_en 
0 16.02.22
EQS-Adhoc: Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
EQS-Adhoc: Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
EQS-Adhoc: Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full Enrollment
eqs_en 
0 16.02.22